# Mustang Bio (MBIO) — Earnings

MBIO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/mbio/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2024 |
| Period end | Jun 30, 2024 |
| EPS actual | −$17.50 |
| EPS estimate | −$7.00 |
| EPS surprise | −150.00% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 13, 2024 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1680048/000155837024012051/tmb-20240630x10q.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2024 | Aug 13, 2024 | −$7.00 | −$17.50 | -150.00% | — | — |
| Q1 2024 | May 15, 2024 | −$43.50 | −$23.00 | 47.13% | — | — |
| Q4 2023 | Mar 11, 2024 | −$77.83 | −$35.50 | 54.39% | — | — |
| Q3 2023 | Nov 14, 2023 | −$63.75 | −$61.50 | 3.53% | — | — |
| Q2 2023 | Aug 14, 2023 | −$90.38 | −$100.00 | -10.65% | — | — |
| Q1 2023 | May 12, 2023 | −$150.50 | −$103.00 | 31.56% | — | — |
| Q4 2022 | Mar 29, 2023 | −$142.50 | −$135.00 | 5.26% | — | — |
| Q3 2022 | Nov 14, 2022 | −$148.13 | −$135.00 | 8.86% | — | — |
| Q2 2022 | Aug 11, 2022 | −$156.00 | −$142.50 | 8.65% | — | — |
| Q1 2022 | May 12, 2022 | −$138.00 | −$150.00 | -8.70% | — | — |
| Q4 2021 | Mar 23, 2022 | −$144.00 | −$165.00 | -14.58% | — | — |
| Q3 2021 | Nov 12, 2021 | −$135.20 | −$142.50 | -5.40% | — | — |
| Q2 2021 | Aug 16, 2021 | −$145.50 | −$120.00 | 17.53% | — | — |
| Q1 2021 | May 14, 2021 | −$140.00 | −$142.50 | -1.79% | — | — |
| Q4 2020 | Mar 24, 2021 | −$155.63 | −$232.50 | -49.40% | — | — |
| Q3 2020 | Nov 6, 2020 | −$187.50 | −$172.50 | 8.00% | — | — |
| Q2 2020 | Aug 10, 2020 | −$200.00 | −$240.00 | -20.00% | — | — |
| Q1 2020 | May 11, 2020 | −$230.00 | −$210.00 | 8.70% | — | — |

## Frequently Asked Questions

### When did Mustang Bio (MBIO) last report earnings?

Mustang Bio last reported on Aug 13, 2024, covering fiscal Q2 2024.

### Did MBIO beat earnings estimates?

No. Mustang Bio reported EPS of −$17.50 for Q2 2024 against a −$7.00 estimate — a 150.00% miss.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).